On December 29, 2023, 17 shares of Common Stock were earned under the terms of the IP Agreement and were issued to Dr. Goode on February 6, 2024. On May 1, 2024, 25 shares of Common Stock were earned under the terms of the IP Agreement. On March 26, 2025, the Board determined that the third milestone was met and that an additional 42 shares of Common Stock have been earned under the terms of the IP Agreement. As of June 30, 2026, the remaining milestones were not considered probable, and no additional compensation expense had been recorded.

$ 93

Loss Contingencies [Line Items]

Contingent consideration liability

$ 93

₪ 420,000

Loss Contingencies [Line Items]

Royalty percentage maximum

5.00%

Commitments and Contingent Liabilities (Details Narrative) $ in Thousands			6 Months Ended
	Oct. 07, 2022 shares	Mar. 04, 2004 USD ($)	Jun. 30, 2026	Mar. 31, 2026 USD ($)	Mar. 04, 2004 ILS (₪)
Loss Contingencies [Line Items]
Description related to IP agreement			On December 29, 2023, 17 shares of Common Stock were earned under the terms of the IP Agreement and were issued to Dr. Goode on February 6, 2024. On May 1, 2024, 25 shares of Common Stock were earned under the terms of the IP Agreement. On March 26, 2025, the Board determined that the third milestone was met and that an additional 42 shares of Common Stock have been earned under the terms of the IP Agreement. As of June 30, 2026, the remaining milestones were not considered probable, and no additional compensation expense had been recorded.
Intellectual Property Purchase Agreement [Member] \| Common Stock [Member]
Loss Contingencies [Line Items]
Number of common shares issued \| shares	167
Israeli Innovation Authority [Member]
Loss Contingencies [Line Items]
Contingent consideration liability \| $		$ 93		$ 93
Minimum [Member] \| Intellectual Property Purchase Agreement [Member] \| Common Stock [Member]
Loss Contingencies [Line Items]
Commission as a percentage of aggregate sales price	1.50%
Israeli Innovation Authority [Member]
Loss Contingencies [Line Items]
Contingent consideration liability		$ 93			₪ 420,000
Israeli Innovation Authority [Member] \| Minimum [Member]
Loss Contingencies [Line Items]
Royalty percentage maximum		3.00%
Israeli Innovation Authority [Member] \| Maximum [Member]
Loss Contingencies [Line Items]
Royalty percentage maximum		5.00%